博文
EML4-ALK融合基因通过激活JAK-STAT通路介导肺腺鳞癌转分化及其耐药
||
EML4-ALK融合基因通过激活JAK-STAT通路介导肺腺鳞癌转分化及其耐药
https://www.ebiotrade.com/newsf/2024-2/20240201064214551.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=39543a54-62eb-4ee2-8e23-5e46e96cc7cf
| 01. | Humans | 4 篇 | 80.000% |
| 02. | Animals | 3 篇 | 60.000% |
| 03. | Lung Neoplasms | 3 篇 | 60.000% |
| 04. | Anaplastic Lymphoma Kinase | 2 篇 | 40.000% |
| 05. | Antineoplastic Agents | 2 篇 | 40.000% |
| 06. | Cell Proliferation | 2 篇 | 40.000% |
| 07. | Oncogene Proteins, Fusion | 2 篇 | 40.000% |
| 08. | Protein Kinase Inhibitors | 2 篇 | 40.000% |
| 09. | Receptor Protein-Tyrosine Kinases | 2 篇 | 40.000% |
| 10. | Apoptosis | 1 篇 | 20.000% |
(30)
(20)
(16)
(15)
(12)
(8)
(6)
(6)
(5)
(5)
(5)
(4)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=EML4-ALK%E8%82%BA%E7%99%8C
https://wap.sciencenet.cn/blog-280034-1420117.html
上一篇：博文评论
下一篇：基于结构的药物设计综述
